August 12, 2013
GlaxoSmithKline LLC scored a win Friday when a Delaware federal judge upheld its patent for the prostate reduction pill Avodart, saying Banner Pharmacaps Inc., Mylan Pharmaceuticals Inc. and other generic-drug makers hadn't shown that the patent was invalid.